Dendritic cells: Nearly 40 years later…

Vázquez, 2012, Células dendríticas I: aspectos básicos de su biología y funciones, Inmunología, 31, 21, 10.1016/j.inmuno.2011.10.001 Liu, 2010, Origin and development of dendritic cells, Immunol Rev, 234, 45, 10.1111/j.0105-2896.2009.00879.x Lundie, 2008, Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells, Proc Natl Acad Sci U S A, 105, 14509, 10.1073/pnas.0806727105 Siegal, 1999, The nature of the principal type 1 interferon-producing cells in human blood, Science, 284, 1835, 10.1126/science.284.5421.1835 Yoneyama, 2004, Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules, Int Immunol, 16, 915, 10.1093/intimm/dxh093 Naik, 2006, Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes, Nat Immunol, 7, 663, 10.1038/ni1340 Cheong, 2010, Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas, Cell, 143, 416, 10.1016/j.cell.2010.09.039 Chorro, 2009, Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network, J Exp Med, 206, 3089, 10.1084/jem.20091586 Steinman, 2003, Tolerogenic dendritic cells, Annu Rev Immunol, 21, 685, 10.1146/annurev.immunol.21.120601.141040 Brocker, 1997, Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo, J Exp Med, 185, 541, 10.1084/jem.185.3.541 Nossal, 1994, Negative selection of lymphocytes, Cell, 76, 229, 10.1016/0092-8674(94)90331-X van Meerwijk, 1997, Quantitative impact of thymic clonal deletion on the T cell repertoire, J Exp Med, 185, 377, 10.1084/jem.185.3.377 Bensinger, 2001, Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells, J Exp Med, 194, 427, 10.1084/jem.194.4.427 Ohnmacht, 2009, Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity, J Exp Med, 206, 549, 10.1084/jem.20082394 Proietto, 2008, Dendritic cells in the thymus contribute to T-regulatory cell induction, Proc Natl Acad Sci U S A, 105, 19869, 10.1073/pnas.0810268105 Wirnsberger, 2009, Regulatory T cell differentiation of thymocytes does not require a dedicated antigen-presenting cell but is under T cell-intrinsic developmental control, Proc Natl Acad Sci U S A, 106, 10278, 10.1073/pnas.0901877106 Bendriss-Vermare, 2001, Human thymus contains IFN-alpha-producing CD11c(−), myeloid CD11c(+), and mature interdigitating dendritic cells, J Clin Invest, 107, 835, 10.1172/JCI11734 Okada, 2003, Murine thymic plasmacytoid dendritic cells, Eur J Immunol, 33, 1012, 10.1002/eji.200323616 Shortman, 2002, Mouse and human dendritic cell subtypes, Nat Rev Immunol, 2, 151, 10.1038/nri746 Vandenabeele, 2001, Human thymus contains 2 distinct dendritic cell populations, Blood, 97, 1733, 10.1182/blood.V97.6.1733 Sakaguchi, 2004, Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses, Annu Rev Immunol, 22, 531, 10.1146/annurev.immunol.21.120601.141122 Watanabe, 2005, Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus, Nature, 436, 1181, 10.1038/nature03886 Martin-Gayo, 2010, Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development, Blood, 115, 5366, 10.1182/blood-2009-10-248260 Ito, 2008, Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery, Immunity, 28, 870, 10.1016/j.immuni.2008.03.018 Young, 2008, Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells, Nat Immunol, 9, 1244, 10.1038/ni.1665 Ardavin, 1993, Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population, Nature, 362, 761, 10.1038/362761a0 de Yebenes, 2002, Identification of a myeloid intrathymic pathway of dendritic cell development marked by expression of the granulocyte macrophage-colony-stimulating factor receptor, Blood, 99, 2948, 10.1182/blood.V99.8.2948 Marquez, 1995, The development of T and non-T cell lineages from CD34+ human thymic precursors can be traced by the differential expression of CD44, J Exp Med, 181, 475, 10.1084/jem.181.2.475 Marquez, 1998, Identification of a common developmental pathway for thymic natural killer cells and dendritic cells, Blood, 91, 2760, 10.1182/blood.V91.8.2760.2760_2760_2771 Fohrer, 2004, Analysis of transcription factors in thymic and CD34+ progenitor-derived plasmacytoid and myeloid dendritic cells: evidence for distinct expression profiles, Exp Hematol, 32, 104, 10.1016/j.exphem.2003.10.007 Weijer, 2002, Intrathymic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo, Blood, 99, 2752, 10.1182/blood.V99.8.2752 Steinman, 2000, The induction of tolerance by dendritic cells that have captured apoptotic cells, J Exp Med, 191, 411, 10.1084/jem.191.3.411 Mellor, 2004, IDO expression by dendritic cells: tolerance and tryptophan catabolism, Nat Rev Immunol, 4, 762, 10.1038/nri1457 Munn, 2005, Dendritic cells have the option to express IDO-mediated suppression or not, Blood, 105, 2618, 10.1182/blood-2005-01-0122 Albert, 2001, Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells, Nat Immunol, 2, 1010, 10.1038/ni722 Lutz, 2000, Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro, Eur J Immunol, 30, 1048, 10.1002/(SICI)1521-4141(200004)30:4<1048::AID-IMMU1048>3.0.CO;2-W Menges, 2002, Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity, J Exp Med, 195, 15, 10.1084/jem.20011341 Yamazaki, 2003, Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells, J Exp Med, 198, 235, 10.1084/jem.20030422 Dhodapkar, 2001, Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells, J Exp Med, 193, 233, 10.1084/jem.193.2.233 Giannoukakis, 2011, Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients, Diabetes Care, 34, 2026, 10.2337/dc11-0472 Reis e Sousa, 2001, Dendritic cells as sensors of infection, Immunity, 14, 495, 10.1016/S1074-7613(01)00136-4 Diebold, 2003, Viral infection switches non-plasmacytoid dendritic cells into high interferon producers, Nature, 424, 324, 10.1038/nature01783 Montoya, 2005, Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN, J Immunol, 174, 1851, 10.4049/jimmunol.174.4.1851 den Haan, 2000, CD8+ but not CD8− dendritic cells cross-prime cytotoxic. T cells in vivo, J Exp Med, 192, 1685, 10.1084/jem.192.12.1685 van der Vlist, 2011, Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4 T cells but are incapable of cross-presentation, Eur J Immunol, 41, 2619, 10.1002/eji.201041305 Tewalt, 2009, Viral sequestration of antigen subverts cross presentation to CD8+ T cells, PLoS Pathog, 5, e1000457, 10.1371/journal.ppat.1000457 De Graaff, 2005, Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells, J Immunol, 175, 5904, 10.4049/jimmunol.175.9.5904 Gonzalez, 2008, Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells, Proc Natl Acad Sci U S A, 105, 14999, 10.1073/pnas.0802555105 Basta, 2002, Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributions from direct priming and cross-priming in induction of vaccinia virus-specific CD8+ T cells, J Immunol, 168, 5403, 10.4049/jimmunol.168.11.5403 Walton, 2011, Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells, PLoS Pathog, 7, e1002214, 10.1371/journal.ppat.1002214 Herter, 2005, Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virus-infected dendritic cells, J Immunol, 175, 891, 10.4049/jimmunol.175.2.891 Norbury, 2002, Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo, Nat Immunol, 3, 265, 10.1038/ni762 Gasteiger, 2007, Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines, J Virol, 81, 11925, 10.1128/JVI.00903-07 Jirmo, 2009, Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1, J Immunol, 182, 283, 10.4049/jimmunol.182.1.283 Xu, 2010, Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response, PLoS Pathog, 6, e1000768, 10.1371/journal.ppat.1000768 Holtappels, 2004, Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues, J Exp Med, 199, 131, 10.1084/jem.20031582 Hill, 1995, Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV) nuclear antigens fail to lyse the EBV-transformed B lymphoblastoid cell lines against which they were raised, J Exp Med, 181, 2221, 10.1084/jem.181.6.2221 Jung, 2002, In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens, Immunity, 17, 211, 10.1016/S1074-7613(02)00365-5 Segura, 2009, Antigen presentation by dendritic cells in vivo, Curr Opin Immunol, 21, 105, 10.1016/j.coi.2009.03.011 Vyas, 2008, The known unknowns of antigen processing and presentation, Nat Rev Immunol, 8, 607, 10.1038/nri2368 Flinsenberg, 2011, Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention, Clin Exp Immunol, 165, 8, 10.1111/j.1365-2249.2011.04411.x Palucka, 2006, Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity, J Immunother, 29, 545, 10.1097/01.cji.0000211309.90621.8b Green, 2009, Immunogenic and tolerogenic cell death, Nat Rev Immunol, 9, 353, 10.1038/nri2545 Maranon, 2004, Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes, Proc Natl Acad Sci U S A, 101, 6092, 10.1073/pnas.0304860101 Harshyne, 2001, Dendritic cells acquire antigens from live cells for cross-presentation to CTL, J Immunol, 166, 3717, 10.4049/jimmunol.166.6.3717 Matheoud, 2011, Dendritic cells crosspresent antigens from live B16 cells more efficiently than from apoptotic cells and protect from melanoma in a therapeutic model, PLoS One, 6, e19104, 10.1371/journal.pone.0019104 Bachem, 2010, Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells, J Exp Med, 207, 1273, 10.1084/jem.20100348 Crozat, 2010, The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells, J Exp Med, 207, 1283, 10.1084/jem.20100223 Hoeffel, 2007, Antigen crosspresentation by human plasmacytoid dendritic cells, Immunity, 27, 481, 10.1016/j.immuni.2007.07.021 Mouries, 2008, Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation, Blood, 112, 3713, 10.1182/blood-2008-03-146290 Jiang, 1995, The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing, Nature, 375, 151, 10.1038/375151a0 Bonifaz, 2002, Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance, J Exp Med, 196, 1627, 10.1084/jem.20021598 Trumpfheller, 2006, Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine, J Exp Med, 203, 607, 10.1084/jem.20052005 Bozzacco, 2007, DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes, Proc Natl Acad Sci U S A, 104, 1289, 10.1073/pnas.0610383104 Trumpfheller, 2008, The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine, Proc Natl Acad Sci U S A, 105, 2574, 10.1073/pnas.0711976105 Trumpfheller, 2012, Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity, J Intern Med, 271, 183, 10.1111/j.1365-2796.2011.02496.x Tacken, 2007, Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting, Nat Rev Immunol, 7, 790, 10.1038/nri2173 Tagliani, 2008, Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells, J Immunol, 180, 3201, 10.4049/jimmunol.180.5.3201 Hart, 2004, A CD91-positive subset of CD11c+ blood dendritic cells: characterization of the APC that functions to enhance adaptive immune responses against CD91-targeted antigens, J Immunol, 172, 70, 10.4049/jimmunol.172.1.70 Wagner, 2009, The immunogenicity of CpG-antigen conjugates, Adv Drug Deliv Rev, 61, 243, 10.1016/j.addr.2008.12.010 Cuadros, 2004, Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses, Infect Immun, 72, 2810, 10.1128/IAI.72.5.2810-2816.2004 Lasarte, 2007, The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo, J Immunol, 178, 748, 10.4049/jimmunol.178.2.748 Melief, 2008, Cancer immunotherapy by dendritic cells, Immunity, 29, 372, 10.1016/j.immuni.2008.08.004 Beckebaum, 2002, Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection, Clin Immunol, 104, 138, 10.1006/clim.2002.5245 Engelmayer, 1999, Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion, J Immunol, 163, 6762, 10.4049/jimmunol.163.12.6762 Majumder, 2005, Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape, J Virol, 79, 7990, 10.1128/JVI.79.13.7990-8003.2005 Sarobe, 2003, Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses, J Virol, 77, 10862, 10.1128/JVI.77.20.10862-10871.2003 Rehermann, 2005, Immunology of hepatitis B virus and hepatitis C virus infection, Nat Rev Immunol, 5, 215, 10.1038/nri1573 Ludewig, 1998, Dendritic cells efficiently induce protective antiviral immunity, J Virol, 72, 3812, 10.1128/JVI.72.5.3812-3818.1998 Shimizu, 1998, Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice, J Immunol, 161, 4520, 10.4049/jimmunol.161.9.4520 Echeverria, 2011, T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells, Hepatology, 54, 28, 10.1002/hep.24325 Huang, 2009, Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells, Clin Vaccine Immunol, 16, 1504, 10.1128/CVI.00104-09 Garcia, 2011, Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1, Vaccine, 29, 6454, 10.1016/j.vaccine.2011.07.043 Akbar, 2011, Safety and immunogenicity of hepatitis B surface antigen-pulsed dendritic cells in patients with chronic hepatitis B, J Viral Hepat, 18, 408, 10.1111/j.1365-2893.2010.01320.x Gowans, 2010, A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals, J Hepatol, 53, 599, 10.1016/j.jhep.2010.05.007 Lin, 2002, Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma, Cancer Res, 62, 6952 Santin, 2008, Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial, J Virol, 82, 1968, 10.1128/JVI.02343-07